A secondary analysis of the 450-patient, randomized ATLAS trial suggests Boston Scientific's Emblem MRI subcutaneous implantable cardioverter defibrillator (S-ICD) can help prevent tricuspid valve regurgitation in arrhythmia patients.
Darryl Leong from McMaster University in Hamilton, Ontario presented the research at the Heart Rhythm 2023 conference in New...